CDK9 Antibody – Mouse Monoclonal

CDK9 (cyclin-dependent kinase 9, serine/threonine-protein kinase PITALRE) is a member of the cell division cycle 2 (CDC2) family of kinases that play a pivotal role in the regulation of the eukaryotic cell cycle. CDK9 expression is ubiquitous, but its expression levels are different in various human tissues. CDK9 is localized primarily to the nucleus. At pathophysiological levels, CDK9 activity suppresses many genes for mitochondrial proteins including master regulators of mitochondrial function (peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1), nuclear respiratory factor-1). Chronic activation of CDK9 causes not only cardiomyocyte enlargement but also defective mitochondrial function. The cyclinT/CDK9 complex, also called positive transcription elongation factor b (p-TEFb), phosphorylates the C-terminal domain of the large subunit of RNA polymerase II, stimulating transcription elongation and pre-mRNA processing.

Small volumes of anti-CDK9 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS6232080 is an antibody targeting CDK9. Also known as CDK9 (Cyclin-dependent Kinase 9, C-2K, Cell Division Cycle 2-like Protein Kinase 4, Cell Division Protein Kinase 9, Serine/Threonine-protein Kinase PITALRE, CDC2L4) (MaxLight 750). Reactive in Human. Host: Mouse.